Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Lipid Regulating Effects of TRIA-662
This study has been completed.
Study NCT00758303   Information provided by Cortria Corporation

First Received on September 23, 2008.   Last Updated on March 12, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperlipidemia
Additional conditions recognized in this trial
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Low Dose TRIA-662
High Dose TRIA-662
Placebo for TRIA-662
Sponsors listed in this trial
Cortria Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services